Dexcom has appointed longtime executive Jake Leach as CEO, highlighting its focus on innovation, global expansion, and next-generation diabetes care solutions.
Dexcom, Inc., a global leader in continuous glucose monitoring (CGM) for people with diabetes, has appointed Jake Leach as its new Chief Executive Officer, effective during a period of strong financial performance in Q2. Leach, a company veteran, has been with Dexcom for over two decades, playing a central role in advancing its technology and product innovation. Most recently, he served as Chief Operating Officer, where he oversaw R&D, operations, and commercialization strategies that positioned Dexcom as a market leader in diabetes care. His promotion comes as Dexcom continues to expand globally, scaling its CGM adoption across new markets and diversifying its product portfolio. Under Leach’s leadership, the company is expected to accelerate efforts in digital health integration, patient accessibility, and next-generation CGM devices. His appointment underscores Dexcom’s commitment to continuity, innovation, and patient-first solutions, ensuring it remains at the forefront of transforming diabetes management worldwide.
WhatsApp
LinkedIn
Facebook
X
Email